ONCORIF - Dispositif Spécifique Régional du Cancer en Île-de-France

What ONCORIF - Dispositif Spécifique Régional du Cancer en Île-de-France does

ONCORIF (Dispositif Spécifique Régional du Cancer en Île-de-France) is the official regional cancer coordination network for the Île-de-France region, operating under a governmental mandate from the French national cancer strategy framework (Instruction DGOS/R3/INCA/2019/248). It functions as an information hub and coordination platform serving all authorized cancer treatment establishments, the 3C (Coordination Centers in Cancerology), healthcare professionals, and patient populations across the region's 8 departments. Its portfolio of digital resources includes a central web portal (www.oncorif.fr), the Le Lab' ONCORIF podcast, OncoClap' video capsules, the 3C coordination toolkit, the Dossier Communicant de Cancérologie (DCC) digital patient record, oral anticancer drug fact sheets, multidisciplinary meeting (RCP) coordination tools, and a monthly newsletter. It also facilitates university diploma programs and professional training in oncology in partnership with Gustave Roussy, Institut Curie, Sorbonne Université, and Université Paris-Saclay.

The organization's underlying technology is non-proprietary and serves as a regional information and coordination layer rather than a commercial product platform; it does not develop or sell proprietary technology products. Its core distribution is through its website, institutional networks of healthcare establishments, professional training programs, and patient-facing resources embedded in regional care pathways.

ONCORIF's business model is entirely publicly funded: its activities are financed 100% by public funds allocated by ARS Île-de-France (Agence Régionale de Santé) under the statutory missions defined by Instruction DGOS/R3/INCA/2019/248. It is structured as a non-profit organization (DSRC ONCORIF), operates no commercial revenue streams, charges no fees for its services or resources, and declares no conflicts of interest with health product companies. The organization is governed by a Board and General Assembly, with Sandra Lefèvre serving as Director and Pr Gérard Zalcman as President.

Name

ONCORIF - Dispositif Spécifique Régional du Cancer en Île-de-France

Legal name

DSRC ONCORIF – Dispositif Spécifique Régional du Cancer en Île-de-France

Website

https://oncorif.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels4 records

Marketing channels8 records

Core offering

ONCORIF is a publicly funded regional cancer coordination network (DSRC) for Île-de-France. It operates as an information hub and coordination platform, providing reference tools, clinical practice guidelines, multidisciplinary meeting (RCP) coordination, professional training, patient information resources, and regional care pathway support across the 8 departments of Île-de-France.

Product overview

ONCORIF is a regional cancer coordination organization (Dispositif Spécifique Régional du Cancer) for Île-de-France, not a commercial product company. Its digital offering consists of a central web portal providing access to professional resources, patient information, and care coordination tools. The portfolio includes the main ONCORIF website portal, the Lab'ONCORIF educational podcast, the OncoClap' video series, the 3C coordination toolkit, the Dossier Communicant de Cancérologie (DCC) patient record system, Anticancéreux oraux medication fact sheets, RCP coordination resources, newsletters, and healthcare directories. These offerings work together to coordinate cancer care across Île-de-France, connecting healthcare professionals, patients, and institutional partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Le Lab'ONCORIF Podcast Audio podcast series launched by ONCORIF for information and training purposes. First season covers thrombosis and cancer, targeting healthcare professionals in Île-de-France as well as patients, caregivers, and students.
• Dossier Communicant de Cancérologie (DCC) Digital patient record system for cancer patients enabling information sharing between healthcare providers across the cancer care pathway in Île-de-France.
• Boîte à outils 3C Toolkit for 3C (Centres de Coordination en Cancérologie) teams providing resources, guides, and operational tools for cancer care coordination in Île-de-France.
• Journée d'Imagerie du Cancer Annual educational event on cancer imaging organized with Institut des Cancers des Femmes, covering topics including AI in breast imaging, AngioMammo, IRM, and therapeutic de-escalation.
• OncoClap' Video Capsules Educational video series covering cancer-related topics including late effects (séquelles) and lymphedema, aimed at patients and healthcare professionals.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

19 partnerships are on record, tiered core and minor.

• ARS Île-de-FrancecoreOthersThe primary funder and regulatory overseer of ONCORIF. ARS Île-de-France provides full funding for ONCORIF's operations under the national cancer strategy framework. ONCORIF's missions are defined by Instruction n° DGOS/R3/INCA/2019/248.
• INCa (Institut national du cancer)coreStrategic or Co-development PartnerThe national French cancer institute provides ONCORIF with formal recognition and coordinates national cancer strategy implementation regionally through ONCORIF. ONCORIF disseminates INCa guidelines, reference documents, and clinical standards throughout Île-de-France.
• Pr Gérard Zalcman (President of ONCORIF)coreOthersPresident of ONCORIF, contributing to institutional leadership and regional coordination of cancer care in Île-de-France.
• RIFHOP (Réseau Île-de-France d'Hématologie-Oncologie Pédiatrique)coreStrategic or Co-development PartnerRegional pediatric hematology-oncology network for Île-de-France, collaborating with ONCORIF on pediatric cancer care coordination and young patient pathways.
• CORPALIF (Coordination en Onco-Hématologie d'Île-de-France)coreStrategic or Co-development PartnerRegional hematology-oncology coordination network in Île-de-France working with ONCORIF on blood cancer care pathways and multidisciplinary coordination.
• CANPEDIF (Cancérologie Pédiatrique Île-de-France)coreStrategic or Co-development PartnerPediatric oncology coordination for Île-de-France, with ONCORIF collaborating on RCPPIs (Réunions de Concertation Pluridisciplinaire Pédiatriques Inter-régionales) for adolescents and young adults.
• CRCDC IDF (Centres Régions de Dépistage des Cancers Île-de-France)coreStrategic or Co-development PartnerRegional cancer screening centers in Île-de-France, collaborating with ONCORIF on cancer prevention, screening promotion, and early detection initiatives.
• AP-HP (Assistance Publique - Hôpitaux de Paris)coreStrategic or Co-development PartnerThe largest hospital system in Europe, AP-HP is a key institutional partner. AP-HP establishments include GH La Pitié-Salpêtrière where ONCORIF's office is located, and various AP-HP hospitals collaborate on cancer care pathways, preservation of fertility (48h access guarantee), and training programs.
• Gustave RoussycoreStrategic or Co-development PartnerOne of Europe's leading cancer centers, located in Villejuif. Gustave Roussy co-develops training programs with ONCORIF (DIU Sciences Cliniques, International Nutrition course) and contributes to regional oncology education and research.
• Institut CuriecoreStrategic or Co-development PartnerLeading French cancer research and treatment center in Paris. Institut Curie partners with ONCORIF on specialized events (Imagerie du Cancer, DIU Soins de Support), clinical guidelines, and professional training.
• CancéropôlecoreStrategic or Co-development PartnerThe regional cancer research pole coordinates oncology research activities in Île-de-France. ONCORIF works with the Cancéropôle on clinical trial promotion and research coordination.
• FROGminorStrategic or Co-development PartnerA regional oncology network or initiative referenced in ONCORIF's data policy as an institutional partner in the Île-de-France cancer ecosystem.
• Sorbonne UniversitécoreStrategic or Co-development PartnerMajor university partner collaborating on oncology education programs, research, and training. AP-HP Sorbonne Université is specifically referenced in connection with October Rose breast cancer conferences.
• Université Paris-SaclaycoreStrategic or Co-development PartnerUniversity partner co-developing the DU Sciences Cliniques en Soins en Cancérologie with Gustave Roussy and ONCORIF for advanced oncology training.
• URPS Pharmaciens Île-de-FrancecoreStrategic or Co-development PartnerRegional union of pharmacists in Île-de-France. ONCORIF collaborated with URPS Pharmaciens on a webinaire dedicated to caregiver support in community pharmacies (June 2025), supporting oral anticancer drug management pathways.
• Centr'AidercoreStrategic or Co-development PartnerRegional caregiver support initiative (dispositif régional de lisibilité de l'offre aux aidants). ONCORIF partners with Centr'Aider for events such as the Centr'aider Yvelines caregiver information sessions and awareness programs.
• UnicancercoreStrategic or Co-development PartnerThe French federation of private cancer centers. ONCORIF works with Unicancer on professional training (IPA congress), clinical practice guidelines, and cancer care coordination, particularly through its member establishments.
• OMEDIT (Observatoire des Médicaments, des Dispositifs médicaux et Innovations Thérapeutiques)minorStrategic or Co-development PartnerRegional medication observatory that supports ONCORIF in maintaining and updating oral anticancer drug fact sheets (fiches médicaments anticancéreux) referenced on the ONCORIF website.
• APUR (Atelier Parisien d'Urbanisme)minorStrategic or Co-development PartnerParis urban planning institute that conducted a study on cancer patient prevention and support in the Grand Paris area, highlighting supportive care needs. ONCORIF relayed this study as a resource for regional cancer care planning.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• ONCO Nouvelle-Aquitaine: DSRC for the Nouvelle-Aquitaine region. Performs the same regional cancer coordination, 3C support, clinical pathway facilitation, and professional training roles as ONCORIF under the national instruction.
• ONCO Grand Est: DSRC for the Grand Est region. Comparable regional coordinator with the same mandate, funding model, and operational scope in oncology care coordination, training, and pathway support.
• ONCO AURA (DSRC Auvergne-Rhône-Alpes): Regional cancer coordination network for the Auvergne-Rhône-Alpes region under the same national DSRC framework (DGOS/R3/INCA/2019/248). Same mandate, funding model, and statutory role as ONCORIF, but serving a different French region — making it the most structurally comparable peer.
• ONCO Occitanie: DSRC for the Occitanie region. Direct structural peer to ONCORIF, operating under identical national framework with parallel regional coordination activities in oncology.
• ONCO Hauts-de-France: DSRC for the Hauts-de-France region. Structurally identical to ONCORIF as a regional cancer coordination network funded by the corresponding ARS, with the same missions and partner ecosystem profile.
• ONCO Centre-Val de Loire: DSRC for the Centre-Val de Loire region. Same national mandate and regional cancer coordination role, comparable operating model and ARS funding structure.
• ONCO Normandie: DSRC for Normandy. Same regulatory designation, ARS funding model, and core mission of coordinating cancer care across 3C centers, multidisciplinary meetings, and professional training.
• ONCO Bretagne: DSRC for Brittany. Operates under the same national mandate with parallel structures for 3C coordination, multidisciplinary meetings (RCP), and regional clinical research facilitation in oncology.
• ONCOPACA-CORSEP (DSRC Provence-Alpes-Côte d'Azur): DSRC for the PACA/Corse region operating under the identical national cancer coordination framework. Shares the same ARS-funded non-profit structure, 3C coordination responsibilities, and content/mission profile as ONCORIF, serving southeastern France.

Broad incumbents

• INCa (Institut national du cancer): The national French cancer institute that oversees and coordinates the DSRC network (including ONCORIF). Operates at the national level rather than regional, sets national clinical guidelines and reference documents that ONCORIF disseminates, and is a core strategic partner of ONCORIF.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubepodcast.ausha.co/le-lab-oncorif
• Facebookfacebook.com/oncorif
• LinkedInlinkedin.com/company/oncorif

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ONCORIF - Dispositif Spécifique Régional du Cancer en Île-de-France